Tarsons Products Limited (NSE:TARSONS) Analysts Are More Bearish Than They Used To Be
Nov 22
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedDec 04, 2023
DataAggregated Company Financials
Companies13
- 7D0.4%
- 3M1.7%
- 1Y13.9%
- YTD15.2%
The Life Sciences industry has been flat over the last week, but Dishman Carbogen Amcis has lost 3.6%. The past year has been better, since the industry has gained 14% in that time. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 04 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.3x | 77.3x | 9x |
| Wed, 01 Nov 2023 | ₹1.3t | ₹156.1b | ₹19.8b | 21x | 63.4x | 8.1x |
| Fri, 29 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.1x | 70.4x | 9x |
| Sun, 27 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 27.6x | 69.2x | 8.8x |
| Tue, 25 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 29.9x | 59.8x | 8.8x |
| Thu, 22 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 29.2x | 57.2x | 8.4x |
| Sat, 20 May 2023 | ₹1.2t | ₹163.0b | ₹28.6b | 32.9x | 41.3x | 7.2x |
| Mon, 17 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 34.7x | 41.3x | 7.3x |
| Wed, 15 Mar 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 30.5x | 36.6x | 6.5x |
| Fri, 10 Feb 2023 | ₹1.1t | ₹158.6b | ₹28.4b | 38.4x | 37.3x | 6.7x |
| Sun, 08 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.5x | 35.8x | 7.5x |
| Tue, 06 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 32.4x | 35.4x | 7.4x |
| Thu, 03 Nov 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 37.5x | 37.3x | 8.2x |
| Sat, 01 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.2x | 36.2x | 8x |
| Mon, 29 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37.2x | 35.8x | 7.9x |
| Wed, 27 Jul 2022 | ₹1.3t | ₹159.0b | ₹34.2b | 33.1x | 37.9x | 8.1x |
| Fri, 24 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.9x | 37.3x | 8.1x |
| Sun, 22 May 2022 | ₹1.4t | ₹149.8b | ₹30.2b | 34.9x | 48x | 9.7x |
| Tue, 19 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 36.9x | 53.1x | 10.5x |
| Thu, 17 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 34.8x | 51.1x | 10.1x |
| Sat, 12 Feb 2022 | ₹1.5t | ₹139.8b | ₹25.1b | 37.6x | 59.1x | 10.6x |
| Mon, 10 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 32.6x | 63.6x | 11.3x |
| Wed, 08 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 30.8x | 64.1x | 11.4x |
| Fri, 05 Nov 2021 | ₹1.7t | ₹132.3b | ₹22.7b | 23.8x | 73.2x | 12.6x |
| Sun, 03 Oct 2021 | ₹1.6t | ₹131.1b | ₹22.9b | 22.7x | 70x | 12.3x |
| Tue, 31 Aug 2021 | ₹1.7t | ₹131.4b | ₹22.9b | 24.9x | 74.3x | 13x |
| Wed, 07 Jul 2021 | ₹1.5t | ₹127.1b | ₹22.6b | 36.9x | 65.2x | 11.6x |
| Sat, 10 Apr 2021 | ₹1.2t | ₹121.4b | ₹21.5b | 32.5x | 56.9x | 10.1x |
| Fri, 01 Jan 2021 | ₹1.3t | ₹116.0b | ₹22.4b | 40x | 58.6x | 11.3x |
Price to Earnings Ratio
55.2x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 77.3x which is higher than its 3-year average PE of 53.6x.
- The industry is trading close to its 3-year average PS ratio of 9.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 6.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 2.45% | |
| Healthcare | 2.15% | |
| Life Sciences | 0.45% | |
| Clinical Research and Equipment | 0.45% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹3.79k | 0.7% +₹7.4b | 12.2% | PE75.6x | |
| SYNGENE Syngene International | ₹746.70 | 0.2% +₹456.8m | 23.9% | PE59.5x | |
| 530239 Suven Life Sciences | ₹84.05 | 1.7% +₹307.5m | 33.1% | PS146.3x | |
| 526853 Bilcare | ₹73.93 | 3.0% +₹49.9m | 97.1% | PE14.6x | |
| 539267 Samsrita Labs | ₹16.30 | 1.9% +₹4.6m | -44.0% | PS1112.4x |
